DataBreaches has previously reported some of the developing news concerning a cyberattack on Cencora/Lash Group. Our coverage focused on affected U.S. entities, but Canadian and UK entities were also affected. Wire News Fax reports:
Medical and personal patient data from Innomar Strategies – a major Canadian pharmaceutical company – was stolen following an intrusion into the parent company’s computer system. Potential victims interviewed by La Presse did not know that this company had access to this sensitive information.
“I have already had my information stolen with the leak from Desjardins and now I learn that it is the information in my medical file that would have been stolen from a company that I do not even know,” says a patient who does not does not want to be named, for fear of breaking the bond of trust with his doctor.
Since being diagnosed with cancer a few years ago, the man has undergone a battery of treatments and participated in several studies.
The company in question is Innomar Strategies. This Canadian subsidiary of Cencora – a US drug distribution giant that was called AmerisourceBergen until last year – manages dozens of patient support programs (PSPs).
Read more at Wire News Fax.
I was notified on June 11/24 by Cencora/ Inomar strategies regarding a breach of a company they represent in which all of my medical history and personal history as well had been compromised.
As a cancer patient reliant on continues care, I’m very concerned about what harm this might lead to. I’ve been told to watch my financial statements closely and monitor all activity.
This is added anxiety I don’t need!